ANTI-LAP ANTIBODY VARIANTS AND THEIR USES

VE6142019000564SUndetermined Publication Date: 2022-02-17MERCK SHARP & DOHME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
MERCK SHARP & DOHME CORP
Filing Date
2019-10-09
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

This document provides anti-LAP antibodies (e.g., humanized, chimeric, and recombinant human anti-LAP antibodies) or antigen-binding fragments thereof that have therapeutically beneficial properties, such as specific binding to LAP-TGFB1 in cells but not to LAP-TGFB1 in the extracellular matrix, as well as compositions containing them. Uses of these antibodies or antigen-binding fragments in therapeutic applications, such as cancer treatment and diagnostic applications, are also provided.